{"id":3881,"date":"2025-09-25T11:04:13","date_gmt":"2025-09-25T04:04:13","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=3881"},"modified":"2025-10-02T14:27:07","modified_gmt":"2025-10-02T07:27:07","slug":"betadex","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/betadex\/","title":{"rendered":"Betadex"},"content":{"rendered":"

Betacyclodextrin<\/p>\n

(Ph. Eur. monograph 1070)<\/p>\n[C6<\/sub>H10<\/sub>O5<\/sub>]7<\/sub>\u00a0 \u00a0 \u00a0 1135\u00a0 \u00a0 \u00a0 7585-39-9<\/p>\n

Action and use<\/strong><\/p>\n

Carrier molecule for drug delivery systems.<\/p>\n

DEFINITION<\/h2>\n

Cycloheptakis-(1\u21924)-(\u03b1-D-glucopyranosyl) (cyclomaltoheptaose, \u03b2-cyclodextrin).<\/p>\n

Content<\/h3>\n

98.0 per cent to 102.0 per cent (dried substance).<\/p>\n

CHARACTERS<\/h2>\n

Appearance<\/h3>\n

White or almost white, amorphous or crystalline, hygroscopic powder.<\/p>\n

Solubility<\/h3>\n

Sparingly soluble in water and in propylene glycol, practically insoluble in anhydrous ethanol and in methylene chloride.<\/p>\n

IDENTIFICATION<\/h2>\n

A. Specific optical rotation (2.2.7): + 160 to + 164 (dried substance), determined on solution S (see Tests).<\/p>\n

B. Examine the chromatograms obtained in the assay.
\nResults The principal peak in the chromatogram obtained with test solution (b) is similar in retention time and size to the principal peak in the chromatogram obtained with reference solution (c).<\/p>\n

C. Dissolve 0.2 g in 2 mL of iodine solution R4 by warming on a water-bath, and allow to stand at room temperature. A yellowish-brown precipitate is formed.<\/p>\n

TESTS<\/h2>\n

Solution S<\/h3>\n

Dissolve 1.000 g in carbon dioxide-free water R with heating, allow to cool and dilute to 100.0 mL with the same solvent.<\/p>\n

Appearance of solution<\/h3>\n

Solution S is clear (2.2.1).<\/p>\n

pH (2.2.3)<\/h4>\n

5.0 to 8.0.<\/p>\n

To 10 mL of solution S add 0.1 mL of a saturated solution of potassium chloride R.<\/p>\n

Reducing sugars<\/h3>\n

Maximum 0.2 per cent.<\/p>\n

Test solution: To 1 mL of solution S add 1 mL of cupri-tartaric solution R4. Heat on a water-bath for 10 min, cool to room temperature. Add 10 mL of ammonium molybdate reagent R1 and allow to stand for 15 min.<\/p>\n

Reference solution: Prepare a reference solution at the same time and in the same manner as the test solution, using 1 mL of a 0.02 g\/L solution of glucose R.<\/p>\n

Measure the absorbance (2.2.25) of the test solution and the reference solution at the absorption maximum at 740 nm using water R as the compensation liquid. The absorbance of the test solution is not greater than that of the reference solution.<\/p>\n

Light-absorbing impurities<\/h3>\n

Examine solution S between 230 nm and 750 nm. Between 230 nm and 350 nm, the absorbance (2.2.25) is not greater than 0.10. Between 350 nm and 750 nm, the absorbance (2.2.25) is not greater than 0.05.<\/p>\n

Related substances<\/h3>\n

Liquid chromatography (2.2.29).<\/p>\n

Test solution (a): Dissolve 0.250 g of the substance to be examined in water R with heating, cool and dilute to 25.0 mL with the same solvent.<\/p>\n

Test solution (b): Dilute 5.0 mL of test solution (a) to 50.0 mL with water R.<\/p>\n

Reference solution (a): Dissolve 25.0 mg of alfadex CRS (impurity A), 25.0 mg of gammacyclodextrin CRS (impurity B) and 50.0 mg of betadex CRS in water R, then dilute to 50.0 mL with the same solvent.<\/p>\n

Reference solution (b): Dilute 5.0 mL of reference solution (a) to 100.0 mL with water R.<\/p>\n

Reference solution (c): Dissolve 25.0 mg of betadex CRS in water R and dilute to 25.0 mL with the same solvent.<\/p>\n

Column:<\/p>\n

\u2014 size: l = 0.25 m, \u00d8 = 4.6 mm;<\/p>\n

\u2014 stationary phase: end-capped octadecylsilyl silica gel for chromatography R (5 \u03bcm).<\/p>\n

Mobile phase: methanol R, water for chromatography R (10:90 V\/V).<\/p>\n

Flow rate: 1.5 mL\/min.<\/p>\n

Detection: Differential refractometer.<\/p>\n

Equilibration: With the mobile phase for about 3 h.<\/p>\n

Injection: 50 \u03bcL of test solution (a) and reference solutions (a) and (b).<\/p>\n

Run time: 2 times the retention time of betadex.<\/p>\n

Identification of impurities: Use the chromatogram obtained with reference solution (a) to identify the peaks due to impurities A and B.<\/p>\n

Relative retention: With reference to betadex (retention time = about 10 min): impurity B = about 0.4; impurity A = about 0.6.<\/p>\n

System suitability: Reference solution (a):<\/p>\n

\u2014 resolution: minimum 1.5 between the peaks due to impurities B and A; if necessary, adjust the concentration of methanol in the mobile phase.<\/p>\n

Calculation of percentage contents:<\/p>\n

\u2014 for impurities A and B, use the concentration of the corresponding impurity in reference solution (b);<\/p>\n

\u2014 for impurities other than A and B, use the concentration of betadex in reference solution (b).<\/p>\n

Limits:<\/p>\n

\u2014 impurities A, B: for each impurity, maximum 0.25 per cent;<\/p>\n

\u2014 sum of impurities other than A and B: maximum 0.5 per cent;<\/p>\n

\u2014 reporting threshold: 0.15 per cent.<\/p>\n

Residual solvents<\/h4>\n

Head-space gas chromatography (2.2.28): use the standard additions method.<\/p>\n

Internal standard: ethylene chloride R.<\/p>\n

Stock solution A: To 20 \u03bcL of ethylene chloride R add 0.5 mL of dimethyl sulfoxide R and dilute to 25.0 mL with water R.<\/p>\n

Stock solution B: To 25 \u03bcL of trichloroethylene R add 25 \u03bcL of toluene R and 0.5 mL of dimethyl sulfoxide R, then dilute to 50.0 mL with water R.<\/p>\n

Test solutions (a), (b), (c) and (d): In each of 4 identical vials, introduce 0.5 g of the substance to be examined, 0.10 g of calcium chloride R, 30 \u03bcL of \u03b1-amylase solution R and 1 mL of reference solutions (a), (b), (c) and (d), respectively, then add 9.0 mL of water R. Prepare test solutions (b), (c) and (d) in triplicate.<\/p>\n

Reference solution (a): Dilute 250 \u03bcL of stock solution A to 10.0 mL with water R.<\/p>\n

Reference solution (b): To 100 \u03bcL of stock solution B add 250 \u03bcL of stock solution A and dilute to 10.0 mL with water R.<\/p>\n

Reference solution (c): To 200 \u03bcL of stock solution B add 250 \u03bcL of stock solution A and dilute to 10.0 mL with water R.<\/p>\n

Reference solution (d): To 300 \u03bcL of stock solution B add 250 \u03bcL of stock solution A and dilute to 10.0 mL with water R.<\/p>\n

Blank solution: In a vial identical to those used for the test solutions, introduce 0.10 g of calcium chloride R, 30 \u03bcL of \u03b1- amylase solution R, 0.5 mL of dimethyl sulfoxide R and 10.0 mL of water R.<\/p>\n

Column:<\/p>\n

\u2014 material: fused silica;<\/p>\n

\u2014 size: l = 25 m, \u00d8 = 0.32 mm;<\/p>\n

\u2014 stationary phase: macrogol 20 000 R (film thickness 1 \u03bcm).<\/p>\n

Carrier gas: helium for chromatography R.<\/p>\n

Flow rate: 1.7 mL\/min.<\/p>\n

Static head-space conditions that may be used: if the equipment has different setting parameters, adjust the equipment settings so as to comply with the system suitability criterion:<\/p>\n

\u2014 equilibration temperature: 45 \u00b0C;<\/p>\n

\u2014 equilibration time: 2 h;<\/p>\n

\u2014 syringe temperature: 50 \u00b0C;<\/p>\n

\u2014 injection speed: 500 \u03bcL\/s.<\/p>\n

Temperature:<\/p>\n

\u2014 column: 50 \u00b0C;<\/p>\n

\u2014 injection port: 140 \u00b0C;<\/p>\n

\u2014 detector: 280 \u00b0C.<\/p>\n

Detection: Flame ionisation.<\/p>\n

Injection: 200 \u03bcL.<\/p>\n

Relative retention: With reference to the internal standard (retention time = about 13 min): trichloroethylene = about 0.6; toluene = about 0.8.<\/p>\n

System suitability: Test solutions (b), (c) and (d):<\/p>\n

\u2014 repeatability: maximum relative standard deviations of the ratios of the areas of the peaks due to trichloroethylene and toluene to that of the peak due to ethylene chloride of 10.0 per cent, for each set of triplicate test solutions and each residual solvent.<\/p>\n

Calculate the content of trichloroethylene and of toluene taking their relative densities to be 1.46 and 0.87, respectively.<\/p>\n

Limits:<\/p>\n

\u2014 trichloroethylene: maximum 10 ppm;<\/p>\n

\u2014 toluene: maximum 10 ppm.<\/p>\n

Loss on drying (2.2.32)<\/h4>\n

Maximum 16.0 per cent, determined on 1.000 g by drying in an oven at 120 \u00b0C for 2 h.<\/p>\n

Sulfated ash (2.4.14)<\/h4>\n

Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n

ASSAY<\/h2>\n

Liquid chromatography (2.2.29) as described in the test for related substances with the following modifications.<\/p>\n

Injection: Test solution (b) and reference solutions (a) and (c).<\/p>\n

System suitability: Reference solution (a):<\/p>\n

\u2014 repeatability: maximum relative standard deviation of 2.0 per cent for the area of the peak due to betadex, determined on 5 injections.<\/p>\n

Calculate the percentage content of [C6<\/sub>H10<\/sub>O5<\/sub>]7<\/sub>\u00a0using the chromatogram obtained with reference solution (c) and taking into account the assigned content of betadex CRS.<\/p>\n

STORAGE<\/h2>\n

In an airtight container.<\/p>\n

IMPURITIES<\/h2>\n

Specified impurities A, B.<\/p>\n

\"Betadex\"<\/p>\n

A. cyclohexakis-(1\u21924)-(\u03b1-D-glucopyranosyl) (alfadex, cyclomaltohexaose, \u03b1-cyclodextrin),<\/p>\n

\"Betadex\"<\/p>\n

B. cyclooctakis-(1\u21924)-(\u03b1-D-glucopyranosyl) (gammadex, cyclomaltooctaose, \u03b3-cyclodextrin).<\/p>\n","protected":false},"excerpt":{"rendered":"

Betacyclodextrin (Ph. Eur. monograph 1070) [C6H10O5]7\u00a0 \u00a0 \u00a0 1135\u00a0 \u00a0 \u00a0 7585-39-9 Action and use Carrier molecule for drug delivery systems. DEFINITION Cycloheptakis-(1\u21924)-(\u03b1-D-glucopyranosyl) (cyclomaltoheptaose, \u03b2-cyclodextrin). Content 98.0 per cent to 102.0 per cent (dried substance). CHARACTERS Appearance White or almost white, amorphous or crystalline, hygroscopic powder. Solubility Sparingly soluble in water and in propylene glycol,…<\/p>\n","protected":false},"author":2,"featured_media":3901,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174,1],"tags":[],"class_list":["post-3881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances","category-volumes-1-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/3881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=3881"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/3881\/revisions"}],"predecessor-version":[{"id":5233,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/3881\/revisions\/5233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/3901"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=3881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=3881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=3881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}